Occudo Quantitative Strategies LP Axsome Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $198,332 - $235,449	2,864 New	2,864 $200,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $1.15 Million - $1.63 Million	-37,505 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $746,724 - $2.56 Million	37,505 New	37,505 $1.24 Million
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $222,018 - $323,398	-3,971 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $263,317 - $343,570	3,971 New	3,971 $324,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.